SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-022700
Filing Date
2024-04-29
Accepted
2024-04-29 08:00:19
Documents
4
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20023222x1_def14a.htm DEF 14A 498184
2 logo_compasstherapeutics.jpg GRAPHIC 52578
3 ny20023222x1_pc01.jpg GRAPHIC 662739
4 ny20023222x1_pc02.jpg GRAPHIC 520446
  Complete submission text file 0001140361-24-022700.txt   2200420
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39696 | Film No.: 24886647
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)